RARA CRAFT DATABASE for FDA Medical Devices
510(k)K211003

FDA DEVICE FACTS

SHOWA(R) Blue Nitrile Powder Free Medical Examination Glove

Showa Best Glove, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJanuary 19, 2022PRODUCT CODELZA

Indications for use

A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner’s hands or fingers to prevent contamination between patient and examiner.

These gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978-05 Standard Practice for Assessment of Medical Glove to Permeation by chemotherapy drugs.

Chemotherapy Drug and concentration Minimum Breakthrough, detection time in minutes, minutes

1) Blenoxane (15.0 mg/ml) 15,000 ppm >240

2) Busulfan (6.0 mg/ml) 6,000 ppm >240

3) Carboplatin (10.0 mg/ml) 10,000 ppm >240

4) Carmustine (3.3 mg/ml) 3,300 ppm 73.7

5) Cisplatin (1.0 mg/ml) 1,000 ppm >240

6) Cyclophosphamide (20.0 mg/ml) 20,000 ppm >240

7) Cytarabine (100.0 mg/ml) 100,000 ppm >240

8) Dacarbazine (10.0 mg/ml) 10,000 ppm >240

9) Daunorubicin HCl (5.0 mg/ml) 5,000 ppm >240

10) Docetaxel (10.0 mg/ml) 10,000 ppm >240 11)Doxorubicin HCl (2.0 mg/ml) 2,000 ppm >240

12) Epirubicin HCl (2.0 mg/ml) 2,000 ppm >240

13) Etoposide (20.0 mg/ml) 20,000 ppm >240

14) Fludarabine (25.0 mg/ml) 25,000 ppm >240

15) Fluorouracil (50.0 mg/ml 50,000 ppm >240

16) Gemcitabine (38.0 mg/ml) 38,000 ppm >240

17) Idarubicin HCl (1.0 mg/ml) 1,000 ppm >240

18) Ifosfamide (50.0 mg/ml) 50,000 ppm >240

19) Irinotecan (20.0 mg/ml) 20,000 ppm >240

20) Mechlorethamine HCl (1.0 mg/ml) 1,000 ppm >240

21) Melphalan (5.0 mg/ml) 5,000 ppm >240

22) Methotrexate (25.0 mg/ml) 25,000 ppm >240

23) Mitomycin C (0.5 mg/ml) 500 ppm >240

24) Mitoxantrone (2.0 mg/ml) 2,000 ppm >240

25) Paclitaxel (6.0 mg/ml) 6,000 ppm >240

26) Rituximab (10.0 mg/ml) 10,000 ppm >240

27) ThioTepa (10.0 mg/ml)10,000 ppm 25.4

28) Trisenox (1.0 mg/ml) 1,000 ppm >240

29) Vincristine Sulfate (1.0 mg/ml) 1,000 ppm >240

The maximum testing time is 240 minutes. Warning: Do not use with Carmustine or ThioTepa.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026